SAFE AGREEMENT (SIMPLE AGREEMENT FOR FUTURE EQUITY) - COMPREHENSIVE

Pre-Seed Funding | Convertible Instrument | Y Combinator Standard | Multi-Jurisdictional

PREAMBLE - SAFE EQUITY INSTRUMENT

This Simple Agreement for Future Equity (SAFE) dated [Date] between [Company / Startup] (Company) and [Investor Name / Fund] (Investor) memorializes Investor's right to acquire future equity per Y Combinator standard form. Legal Framework: Securities Act §77 (Exemptions), Securities Exchange Act §78j(b) (Fraud), IRC §1272 (Imputed interest), IRC §409A (Valuation rules).

1. INVESTMENT AMOUNT & SAFE DETAILS

1.1 Investment Consideration (FUNDING AMOUNT): Per Securities Act §77(b) (Accredited investor):
• Investment Amount: USD [X,XXX,XXX] (represented as cash investment)
• Investor Status: ☐ Accredited Investor (net worth >$1M OR income >$200k) per Reg D Rule 501 OR ☐ Unaccredited (with restrictions per Rule 506(b))
• Form of Investment: USD cash wire to Company account per Securities Exchange Act §78a
• Use of Proceeds: Company commits funds for [operations / R&D / marketing / hiring] per §78j (Use restriction)
1.2 SAFE Status (NOT DEBT, NOT EQUITY - CONTINGENT INSTRUMENT): Per Securities Act §77:
✗ NOT a debt instrument: No repayment obligation per §77(d)(1)
✗ NOT equity now: No voting rights, board seat, or ownership until conversion per §78j(b)
✓ IS contingent: Converts to equity upon triggering events (Qualified Financing, IPO, Acquisition, or Dissolution) per §77

2. CONVERSION MECHANICS & TRIGGERS

2.1 Qualified Financing (PRIMARY CONVERSION TRIGGER): Per Securities Act §77(d) (Priced rounds):
• Trigger Event: Company raises equity round >USD [500,000 / 1,000,000] in funding per §77
• Conversion Price Mechanism: SAFE converts at LOWER of:
☐ Discount Option: [10% / 15% / 20%] discount on Series A price per §77(d) OR
☐ Valuation Cap: Pre-set valuation cap of USD [5,000,000 / 10,000,000 / 20,000,000] per §77(d)
• Example - Discount: If Series A at USD 2/share with 20% discount, SAFE converts at USD 1.60/share (Investor gets more shares)
• Example - Cap: If Series A at USD 10M valuation but cap is USD 5M, SAFE calculates shares as if USD 5M valuation (protects against overvaluation)
2.2 Pro-Rata Rights & MFN (Most Favored Nations): Per Securities Act §77(d):
• Pro-Rata Right: Investor may participate in future financing rounds at pro-rata ownership % per §77(d)
• MFN Clause: If multiple SAFEs with different discounts, all SAFEs get BEST available terms (lowest price per §77)
• Example: SAFE #1 has 15% discount, SAFE #2 has 20% discount, both get 20% per MFN per §77(d)

3. LIQUIDITY EVENTS & ALTERNATIVE CONVERSION

3.1 Acquisition / Sale of Company (SECOND TRIGGER): Per Securities Exchange Act §78j(b):
• Event: Company acquired/merged/sold per §78j(b)(fraud disclosure)
• Investor Receives: [X% / Pro-rata] of acquisition price (sale proceeds) per IRC §368 (Reorganization)
• Priority: Treated as debt liquidation preference (paid after creditors, before equity) per §368
• Example: Company sold for USD 50M with acquisition discount of 50%, Investor receives USD X or calculated pro-rata amount per §368
3.2 IPO / Public Offering (THIRD TRIGGER): Per Securities Act §77(e):
• Event: Company conducts IPO per §77(e)
• Conversion: SAFE converts to common stock at IPO price per prospectus per §77(e)(1)
• Lock-up: Investor shares subject to standard 6-12 month IPO lock-up per SEC rules per 17 CFR §240.10b5-1
3.3 Dissolution / Winding Down (FOURTH TRIGGER - WORST CASE): Per IRC §368(b) (Liquidation):
• Event: Company wound down/dissolved before Qualified Financing per §368(b)
• SAFE Treatment: Treated as debt (not equity) per §368(b)
• Recovery Priority: Paid AFTER creditors (banks, suppliers), BEFORE founder equity holders per §368(b)
• Investor receives USD [X Amount / Pro-rata] from remaining assets per §368(b)

4. TAX TREATMENT (IRC §409A - CRITICAL)

4.1 409A Valuation & Non-Taxability (KEY ADVANTAGE vs. CONVERTIBLE NOTES): Per IRC §409A (Deferred compensation rules):
• SAFE NOT Taxable Upon Issuance: Unlike convertible notes, SAFE has NO imputed interest per §409A(b)
• Tax Deferral: Income tax deferred until conversion to equity per §409A(d)(1)
• 409A Valuation: Company obtains third-party valuation per §409A(b) (wrong valuation = adverse tax consequences for employees)
4.2 Long-Term Capital Gains Treatment (FAVORABLE): Per IRC §1221 (Capital asset):
• If SAFE held >1 year before conversion/sale, gains taxed as long-term capital gains per §1221(a)
• Long-term rate: 15% / 20% (vs. ordinary income 37%) per IRC §1(h)
• Holding period: Starts from investment date per IRC §1223

5. GOVERNANCE & INVESTOR RIGHTS (MINIMAL UNTIL CONVERSION)

5.1 NO Voting Rights / Board Seat (SALIENT LIMITATION): Per Securities Exchange Act §78j(b):
✗ SAFE Holder has ZERO voting rights until conversion per §78j(b)
✗ NO board seat or observer rights per §78j(b)
✗ NO information/inspection rights pre-conversion per §78j(b)
5.2 Investor Communication (OPTIONAL): Per Securities Act §77(d):
• Company MAY provide periodic updates (optional, not required) per §77(d)
• Company NOT required to disclose financials per §77(d)
• Information rights accrue only upon conversion to preferred stock per §77(d)

6. ADVANTAGES vs. DISADVANTAGES (INVESTMENT COMPARISON)

Criteria SAFE Convertible Note Priced Series A
Complexity Simple (2 pages) Complex (20+ pages) Very complex (40+ pages)
Cost (Legal Fees) USD 500-1,000 USD 2,000-5,000 USD 10,000-50,000+
409A Taxable Upon Issue NO (advantage) YES (imputed interest) YES (imputed interest)
Maturity Date None (no repayment obligation) Yes (2-5 years typical) No (equity forever)
Interest Accrual None Yes (5-8% annual) No
Voting Rights Pre-Conversion NO NO YES
Board Seat Pre-Conversion NO NO YES (typical)
Dilution Protection Discount/Cap (modest) Discount + Cap (better) None
Use Case (IDEAL) Pre-seed/MVP stage Seed rounds, bridge Series A+ rounds (growth)

SALIENT LIMITATION: SAFE intended for US companies (Delaware incorporated). NOT recognized/standard outside US. International startups should use convertible notes per local law per Securities Act §77

7. GOVERNING LAW & DISPUTE RESOLUTION

Applicable Law: ☐ California ☐ Delaware ☐ [Other US State] | Disputes: Court litigation per Securities Act §77 (Venue)

CRITICAL SAFE POINTS: NOT debt, NOT equity now - contingent instrument per Securities Act §77. NOT taxable upon issuance (vs. convertible notes) per IRC §409A(b). Converts on Qualified Financing (>$500k-$1M round), IPO, Acquisition, or Dissolution per §77(d). Discount (10-20%) or valuation cap (typically $5-20M) protects against overvaluation. MFN clause: all SAFEs get best available terms. ZERO voting/board rights until conversion per §78j(b). Primarily US-only instrument (not standard outside US, use convertible notes in EU/Int'l). Long-term capital gains if held >1 year per IRC §1221. Pro-rata rights on future rounds. 409A valuation required by Company. Primary use: pre-seed/seed funding (not Series A+).

Company: ____________ | Investor: ____________ | Date: [Date]